AIM: To review current applications of the laparoscopic surgery while highlighting the
standard procedures across different fields. METHODS: A comprehensive search was …

This selection from the NCCN Guidelines for Rectal Cancer focuses on management of
malignant polyps and resectable nonmetastatic rectal cancer because important updates …

Background The risks of local recurrence and treatment-related morbidity need to be
balanced after local excision of early rectal cancer. The aim of this meta-analysis was to …

The incidence of rectal cancer in the European Union is $125 000 per year, ie $35% of the
total colorectal cancer incidence, reflecting 15–25 cases/100000 population per year and is …

The NCCN Guidelines for Rectal Cancer provide recommendations for the diagnosis,
evaluation, treatment, and follow-up of patients with rectal cancer. These NCCN Guidelines …

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Rectal Cancer
address diagnosis, staging, surgical management, perioperative treatment, management of …

Background Radical surgery via total mesorectal excision might not be the optimal first-line
treatment for early-stage rectal cancer. An organ-preserving strategy with selective total …

Aim Organ‐saving treatment for early‐stage rectal cancer can reduce patient‐reported side
effects compared to standard total mesorectal excision (TME) and preserve quality of life. An …

Background Adequate MRI-based staging of early rectal cancers is essential for decision-
making in an era of organ-conserving treatment approaches. The aim of this population …

At the time of diagnosis synchronous colorectal cancer, liver metastases (SCRLM) account
for 15–25% of patients. If primary tumour and synchronous liver metastases are resectable …